KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $44.5 billion.

  • Bristol Myers Squibb's Non-Current Debt fell 863.91% to $44.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $44.5 billion, marking a year-over-year decrease of 863.91%. This contributed to the annual value of $47.6 billion for FY2024, which is 2987.48% up from last year.
  • As of Q3 2025, Bristol Myers Squibb's Non-Current Debt stood at $44.5 billion, which was down 863.91% from $44.5 billion recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Non-Current Debt peaked at $49.5 billion during Q1 2024, and registered a low of $32.1 billion during Q3 2023.
  • Over the past 5 years, Bristol Myers Squibb's median Non-Current Debt value was $39.7 billion (recorded in 2021), while the average stood at $41.1 billion.
  • Per our database at Business Quant, Bristol Myers Squibb's Non-Current Debt crashed by 1806.31% in 2021 and then surged by 5145.78% in 2024.
  • Bristol Myers Squibb's Non-Current Debt (Quarter) stood at $39.6 billion in 2021, then decreased by 11.49% to $35.1 billion in 2022, then increased by 4.56% to $36.7 billion in 2023, then rose by 29.87% to $47.6 billion in 2024, then dropped by 6.58% to $44.5 billion in 2025.
  • Its Non-Current Debt stands at $44.5 billion for Q3 2025, versus $44.5 billion for Q2 2025 and $46.2 billion for Q1 2025.